• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.在C6和C7缺陷个体中检测到具有功能活性的补体蛋白C6和C7。
Clin Exp Immunol. 1991 Mar;83(3):430-7. doi: 10.1111/j.1365-2249.1991.tb05656.x.
2
[C6, C7, C8 and C9].[C6、C7、C8和C9]。
Nihon Rinsho. 2010 Jun;68 Suppl 6:90-3.
3
[Immunologic tests: C6, C7, C8 and C9].[免疫学检测:补体成分6、补体成分7、补体成分8和补体成分9]
Nihon Rinsho. 2005 Jul;63 Suppl 7:92-4.
4
[Clinical significance of C6, C7, C9 and C1-INH analysis].[C6、C7、C9及C1抑制物分析的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:662-5.
5
Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.单克隆抗体对末端补体复合物形成和细胞裂解的抑制作用。
Complement Inflamm. 1991;8(5-6):328-40. doi: 10.1159/000463204.
6
Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7, and C9 components.人类补体C6、C7和C9成分遗传性缺陷中沉默等位基因(*Q0)的基因检测。
Am J Med Genet. 1995 Feb 13;55(4):408-13. doi: 10.1002/ajmg.1320550405.
7
Familial late complement component (C6, C7) deficiency with chronic meningococcemia.
Arch Intern Med. 1980 Jul;140(7):929-33.
8
Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency.在C6部分缺乏的人类受试者中发现的低分子量补体成分C6的特性。
Immunology. 1992 Jan;75(1):10-6.
9
Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum.C8β缺陷血浆和血清中组装的可溶性末端补体复合物的特征分析。
Scand J Immunol. 1998 Sep;48(3):261-8. doi: 10.1046/j.1365-3083.1998.00390.x.
10
Use of C6- and C7-deficient human sera in quantitative hemolytic assays for C6 and C7.
J Immunol Methods. 1979;30(3):201-7. doi: 10.1016/0022-1759(79)90094-2.

引用本文的文献

1
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis.补体在重症肌无力发病机制及治疗中的作用
Cells. 2025 May 19;14(10):739. doi: 10.3390/cells14100739.
2
Identification of a novel mutation in the C6 gene of a Han Chinese C6SD child with meningococcal disease.一名患脑膜炎球菌病的中国汉族C6SD儿童C6基因新突变的鉴定。
Exp Ther Med. 2021 May;21(5):510. doi: 10.3892/etm.2021.9941. Epub 2021 Mar 19.
3
Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes.开发一种抗人补体 C6 的单克隆抗体,抑制膜攻击复合物的组装。
Blood Adv. 2020 May 12;4(9):2049-2057. doi: 10.1182/bloodadvances.2020001690.
4
Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population.健康白种人群中补体活性和补体水平的年龄和性别相关变化。
Front Immunol. 2018 Nov 20;9:2664. doi: 10.3389/fimmu.2018.02664. eCollection 2018.
5
Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.系统抑制膜攻击复合物可阻碍慢性复发型实验性自身免疫性脑脊髓炎的神经炎症。
Acta Neuropathol Commun. 2018 May 3;6(1):36. doi: 10.1186/s40478-018-0536-y.
6
Functional Complement Analysis Can Predict Genetic Testing Results and Long-Term Outcome in Patients With Complement Deficiencies.功能互补分析可预测补体缺陷患者的基因检测结果和长期预后。
Front Immunol. 2018 Mar 21;9:500. doi: 10.3389/fimmu.2018.00500. eCollection 2018.
7
Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.第六补体成分(C6Q0)完全缺乏,易感染脑膜炎奈瑟菌,以及南非人 C6Q0 基因缺陷频率分析。
Clin Exp Immunol. 2012 Mar;167(3):459-71. doi: 10.1111/j.1365-2249.2011.04525.x.
8
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.疫苗诱导的针对B群脑膜炎奈瑟菌的调理吞噬免疫
Clin Vaccine Immunol. 2008 May;15(5):799-804. doi: 10.1128/CVI.00036-08. Epub 2008 Mar 19.
9
Complement component C7 deficiency in two Spanish families.两个西班牙家庭中的补体成分C7缺乏症
Immunology. 2004 Dec;113(4):518-23. doi: 10.1111/j.1365-2567.2004.01997.x.
10
Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?补体膜攻击复合物II基因簇(C6、C7、C9)缺陷:C6部分缺陷是否具有特殊的进化优势?
Clin Exp Immunol. 2003 Aug;133(2):156-9. doi: 10.1046/j.1365-2249.2003.02230.x.

本文引用的文献

1
Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12.源于大肠杆菌K12的双重溶源菌株生长过程中新溶源类型的分离
Genetics. 1954 Jul;39(4):440-52. doi: 10.1093/genetics/39.4.440.
2
Deficiency of C7 with systemic lupus erythematosus: solubilization of immune complexes in complement-deficient sera.C7缺乏与系统性红斑狼疮:补体缺陷血清中免疫复合物的溶解
Arthritis Rheum. 1981 Jan;24(1):87-93. doi: 10.1002/art.1780240114.
3
A lupus-like syndrome in a patient with deficiency of the sixth component of complement.一名补体第六成分缺乏患者出现的狼疮样综合征。
Arthritis Rheum. 1981 Nov;24(11):1438-40. doi: 10.1002/art.1780241119.
4
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease.散发性脑膜炎球菌病患者先天性或后天性补体缺陷的患病率。
N Engl J Med. 1983 Apr 21;308(16):913-6. doi: 10.1056/NEJM198304213081601.
5
Functional identification of serum complement components following electrophoresis in polyacrylamide gels containing sodium dodecyl sulphate.
J Immunol Methods. 1983 Apr 15;59(1):63-71. doi: 10.1016/0022-1759(83)90146-1.
6
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.荷兰一个家族中补体第六成分和凝血因子 VIII 凝血活性的联合遗传性缺乏。
Clin Exp Immunol. 1982 Jun;48(3):733-8.
7
Inherited complement component deficiencies in membranoproliferative glomerulonephritis.膜增生性肾小球肾炎中的遗传性补体成分缺陷
Kidney Int. 1983 Nov;24(5):681-90. doi: 10.1038/ki.1983.211.
8
Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.补体缺陷状态与感染:免疫缺陷状态下奈瑟菌及其他感染的流行病学、发病机制及后果
Medicine (Baltimore). 1984 Sep;63(5):243-73.
9
A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.补体第六成分(C6)缺乏的家兔的血液凝固异常及其通过纯化的C6的纠正。
J Exp Med. 1971 Dec 1;134(6):1591-600. doi: 10.1084/jem.134.6.1591.
10
The behaviour of complement and platelets in lethal endotoxin shock in rabbits.补体和血小板在兔致死性内毒素休克中的行为表现。
Int Arch Allergy Appl Immunol. 1973;45(1):193-205. doi: 10.1159/000231028.

在C6和C7缺陷个体中检测到具有功能活性的补体蛋白C6和C7。

Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.

作者信息

Würzner R, Orren A, Potter P, Morgan B P, Ponard D, Späth P, Brai M, Schulze M, Happe L, Götze O

机构信息

Department of Immunology, University of Göttingen, Germany.

出版信息

Clin Exp Immunol. 1991 Mar;83(3):430-7. doi: 10.1111/j.1365-2249.1991.tb05656.x.

DOI:10.1111/j.1365-2249.1991.tb05656.x
PMID:2004484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1535307/
Abstract

Two sensitive sandwich ELISAs based on monoclonal antibodies directed to native C6 and C7 allowed the detection and quantitation of these complement proteins in 20 out of 37 serum samples from individuals who had previously been classified as deficient in these proteins as assessed by immunochemical and/or functional assays. Furthermore, serum from four C6-deficient and one combined C6-/C7-deficient individual showed an increase in the terminal complement complex (TCC) and a decrease in native C6 and C7 after complement activation as assayed by specific ELISAs. Despite their (incomplete) deficiencies, these individuals therefore possess functionally active terminal complement proteins with respect to their ability to generate the TCC. As these individuals have no history of a susceptibility to neisserial infections, even low concentrations of functionally active C6 and C7 may provide sufficient protection against those micro-organisms whose destruction requires TCC formation.

摘要

两种基于针对天然C6和C7的单克隆抗体的灵敏夹心酶联免疫吸附测定(ELISA),能够对37份血清样本中的20份进行这些补体蛋白的检测和定量,这些血清样本来自之前经免疫化学和/或功能测定被归类为这些蛋白缺乏的个体。此外,通过特异性ELISA检测发现,来自4名C6缺乏个体和1名C6/C7联合缺乏个体的血清在补体激活后,终末补体复合物(TCC)增加,天然C6和C7减少。尽管这些个体存在(不完全)缺陷,但就其产生TCC的能力而言,他们拥有功能活性的终末补体蛋白。由于这些个体没有感染奈瑟菌的易感性病史,因此即使是低浓度的功能活性C6和C7也可能为抵御那些需要形成TCC才能被破坏的微生物提供足够的保护。